ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Thalassemia is on this study

  • ClinicalTrials.gov filed the study under Thalassemia; it no longer does.
  • GPT-6 Astra (Medium) judged the term right family, but the study is about something narrower. Oct 20 (day only)
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Thalassemia.
  • Rule based: the finest condition the study states.
1 links0 made here, not in the record4 judgments2 judges (the rules as one: Rule based)1 record change seen
GPT-6 Astra (Medium)Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT05773729Safety and Efficacy of GeneModified AutologousHematopoietic Stem Cells toTreat Transfusion-dependentBeta-thalassemiaShanghai BDgene Co., Ltd.NA · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSThalassemiaNo longer in the registry's filing›Oct 20 · GPT-6 Astra (Medium) · Finer: beta-ThalassemiaNov 8 · Rule based · The registry no longer files it hereNov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain condition

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Oct 20ThalassemiaGPT-6 Astra (Medium)Finer: beta-ThalassemiaCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 8ThalassemiaRule based · nightly checkThe registry no longer files it hereCurrent
Nov 14ThalassemiaRule based · condition-kind ruleFinest filed termCurrent
As of nowThalassemiaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.

When a study changes after it was read

Every night, studies whose record changed are compared with the last reading. A change to sites or dates leaves the reading as it is; a reworded entry keeps it; a change to the treatments or conditions marks it to be read again.

Until it is read again, the page shows the last reading and says so.